Identification of genes regulating migration and invasion using a new model of metastatic prostate cancer.

Abstract:

BACKGROUND:Understanding the complex, multistep process of metastasis remains a major challenge in cancer research. Metastasis models can reveal insights in tumor development and progression and provide tools to test new intervention strategies. METHODS:To develop a new cancer metastasis model, we used DU145 human prostate cancer cells and performed repeated rounds of orthotopic prostate injection and selection of subsequent lymph node metastases. Tumor growth, metastasis, cell migration and invasion were analyzed. Microarray analysis was used to identify cell migration- and cancer-related genes correlating with metastasis. Selected genes were silenced using siRNA, and their roles in cell migration and invasion were determined in transwell migration and Matrigel invasion assays. RESULTS:Our in vivo cycling strategy created cell lines with dramatically increased tumorigenesis and increased ability to colonize lymph nodes (DU145LN1-LN4). Prostate tumor xenografts displayed increased vascularization, enlarged podoplanin-positive lymphatic vessels and invasive margins. Microarray analysis revealed gene expression profiles that correlated with metastatic potential. Using gene network analysis we selected 3 significantly upregulated cell movement and cancer related genes for further analysis: EPCAM (epithelial cell adhesion molecule), ITGB4 (integrin β4) and PLAU (urokinase-type plasminogen activator (uPA)). These genes all showed increased protein expression in the more metastatic DU145-LN4 cells compared to the parental DU145. SiRNA knockdown of EpCAM, integrin-β4 or uPA all significantly reduced cell migration in DU145-LN4 cells. In contrast, only uPA siRNA inhibited cell invasion into Matrigel. This role of uPA in cell invasion was confirmed using the uPA inhibitors, amiloride and UK122. CONCLUSIONS:Our approach has identified genes required for the migration and invasion of metastatic tumor cells, and we propose that our new in vivo model system will be a powerful tool to interrogate the metastatic cascade in prostate cancer.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Banyard J,Chung I,Migliozzi M,Phan DT,Wilson AM,Zetter BR,Bielenberg DR

doi

10.1186/1471-2407-14-387

subject

Has Abstract

pub_date

2014-05-30 00:00:00

pages

387

issn

1471-2407

pii

1471-2407-14-387

journal_volume

14

pub_type

杂志文章
  • A new score predicting the survival of patients with spinal cord compression from myeloma.

    abstract:BACKGROUND:This study was performed to create and validate a scoring system for the survival of patients with malignant spinal cord compression (SCC) from myeloma. METHODS:Of the entire cohort (N = 216), 108 patients were assigned to a test group and 108 patients to a validation group. In the test group, nine pre-trea...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-425

    authors: Douglas S,Schild SE,Rades D

    更新日期:2012-09-25 00:00:00

  • Analysis of the impact of platinum-based combination chemotherapy in small cell cervical carcinoma: a multicenter retrospective study in Chinese patients.

    abstract:BACKGROUND:Small cell cervical carcinoma (SCCC) is a rare, aggressive tumor with a poor prognosis. However, information in relation to its treatment is scarce due to the limited numbers of patients. The aim of this study was to establish whether platinum-based combination chemotherapy may by beneficial in this patient ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-14-140

    authors: Huang L,Liao LM,Liu AW,Wu JB,Cheng XL,Lin JX,Zheng M

    更新日期:2014-02-27 00:00:00

  • miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL.

    abstract:BACKGROUND:The origin and development of breast cancer remain complex and obscure. Recently, microRNA (miRNA) has been identified as an important regulator of the initiation and progression of breast cancer, and some studies have shown the essential role of miR-124-3p as a tumor suppressor in breast tumorigenesis. Howe...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2862-4

    authors: Wang Y,Chen L,Wu Z,Wang M,Jin F,Wang N,Hu X,Liu Z,Zhang CY,Zen K,Chen J,Liang H,Zhang Y,Chen X

    更新日期:2016-11-15 00:00:00

  • A novel algorithm for the treatment strategy for advanced epithelial ovarian cancer: consecutive imaging, frailty assessment, and diagnostic laparoscopy.

    abstract:BACKGROUND:This study aimed to evaluate the perioperative outcomes and prognostic impact of the consecutive steps of imaging, frailty assessment, and diagnostic laparoscopy (DLS) in patients with advanced epithelial ovarian cancer (EOC). METHODS:Patients diagnosed with EOC during 2012-2015 were analyzed retrospectivel...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3476-1

    authors: Eoh KJ,Yoon JW,Lee JY,Nam EJ,Kim S,Kim SW,Kim YT

    更新日期:2017-07-12 00:00:00

  • Lipid accumulation impairs natural killer cell cytotoxicity and tumor control in the postoperative period.

    abstract:BACKGROUND:Natural killer (NK) cell dysfunction following cancer surgery has been shown to promote metastases. Recent studies demonstrate an emerging role for lipids in the modulation of NK cell innate responses. However, the mechanisms involved in lipid modulation of NK cell postoperative anti-tumor function are unkno...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6045-y

    authors: Niavarani SR,Lawson C,Bakos O,Boudaud M,Batenchuk C,Rouleau S,Tai LH

    更新日期:2019-08-20 00:00:00

  • Using digital health to facilitate compliance with standardized pediatric cancer treatment guidelines in Tanzania: protocol for an early-stage effectiveness-implementation hybrid study.

    abstract:BACKGROUND:In high-income countries (HICs), increased rates of survival among pediatric cancer patients are achieved through the use of protocol-driven treatment. Compared to HICs, differences in infrastructure, supportive care, and human resources, make compliance with protocol-driven treatment challenging in low- and...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6611-3

    authors: Vasudevan L,Schroeder K,Raveendran Y,Goel K,Makarushka C,Masalu N,Zullig LL

    更新日期:2020-03-29 00:00:00

  • The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations.

    abstract:BACKGROUND:The EGFR-T790M mutation is clinically detected using re-biopsy in approximately 50% of patients with acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) in advanced non-small cell lung cancer (NSCLC) who harbor EGFR mutations. However, little is known about the popu...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5153-4

    authors: Yoshimura A,Yamada T,Okura N,Takeda T,Furutani W,Kubota Y,Shiotsu S,Hiranuma O,Nishioka N,Chihara Y,Tamiya N,Kaneko Y,Uchino J,Takayama K

    更新日期:2018-12-11 00:00:00

  • Effectiveness of intravitreal chemotherapy-assisted endoresection in monocular patients with group D retinoblastoma.

    abstract:BACKGROUND:This study aimed to determine the efficacy and complications of intravitreal chemotherapy-assisted endoresection for refractory International Classification of Retinoblastoma (ICRB) group D retinoblastoma in monocular patients. METHODS:In this retrospective case series, intravitreal chemotherapy-assisted en...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07314-1

    authors: Yu X,Li X,Xing Y,Lu S,Tanumiharjo S,Ma J

    更新日期:2020-08-26 00:00:00

  • Low prevalence of p16-positive HPV-related head-neck cancers in Thailand: tertiary referral center experience.

    abstract:BACKGROUND:There has been a sharp rise in the incidence of human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma (OPSCC) in many countries. Patients with HPV-positive OPSCC have a more favorable prognosis compared with HPV-negative OPSCC, leading to investigation and adoption of de-escalation trea...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6266-0

    authors: Nopmaneepaisarn T,Tangjaturonrasme N,Rawangban W,Vinayanuwattikun C,Keelawat S,Bychkov A

    更新日期:2019-11-06 00:00:00

  • GENESIS: a French national resource to study the missing heritability of breast cancer.

    abstract:BACKGROUND:Less than 20% of familial breast cancer patients who undergo genetic testing for BRCA1 and BRCA2 carry a pathogenic mutation in one of these two genes. The GENESIS (GENE SISter) study was designed to identify new breast cancer susceptibility genes in women attending cancer genetics clinics and with no BRCA1/...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-2028-9

    authors: Sinilnikova OM,Dondon MG,Eon-Marchais S,Damiola F,Barjhoux L,Marcou M,Verny-Pierre C,Sornin V,Toulemonde L,Beauvallet J,Le Gal D,Mebirouk N,Belotti M,Caron O,Gauthier-Villars M,Coupier I,Buecher B,Lortholary A,Dugast

    更新日期:2016-01-12 00:00:00

  • A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.

    abstract:BACKGROUND:Cancer vaccine is one of the attractive treatment modalities for patients with castration-resistant prostate cancer (CRPC). However, because of delayed immune responses, its clinical benefits, besides for overall survival (OS), are not well captured by the World Health Organization (WHO) and Response Evaluat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-613

    authors: Noguchi M,Moriya F,Suekane S,Ohnishi R,Matsueda S,Sasada T,Yamada A,Itoh K

    更新日期:2013-12-30 00:00:00

  • Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301).

    abstract:BACKGROUND:Preoperative chemoradiotherapy (CRT), the current standard of care for locally advanced rectal cancer (LARC), is associated with many radiotherapy (RT)-related side effects. We aimed to evaluate whether S-1 and oxaliplatin (SOX) or folinic acid, 5-FU, and oxaliplatin (mFOLFOX6) can be as effective as neoadju...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07766-5

    authors: Miwa K,Oki E,Enomoto M,Ihara K,Ando K,Fujita F,Tominaga M,Mori S,Nakayama G,Shimokawa M,Saeki H,Baba H,Mori M,Akagi Y

    更新日期:2021-01-05 00:00:00

  • Early life socioeconomic environment and mammographic breast density.

    abstract:BACKGROUND:Early life social environment may influence breast cancer through shaping risk factors operating in early life, adolescence and adulthood, or may be associated with breast cancer risk independent of known risk factors. We investigated the associations between early life socioeconomic status (SES) and mammogr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-3010-x

    authors: Tehranifar P,Cohn BA,Flom JD,Protacio A,Cirillo P,Lumey LH,Michels KB,Terry MB

    更新日期:2017-01-10 00:00:00

  • Angiopoietin-1 deficiency increases tumor metastasis in mice.

    abstract:BACKGROUND:Angipoietin-1 activation of the tyrosine kinase receptor Tek expressed mainly on endothelial cells leads to survival and stabilization of endothelial cells. Studies have shown that Angiopoietin-1 counteracts permeability induced by a number of stimuli. Here, we test the hypothesis that loss of Angiopoietin-1...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3531-y

    authors: Michael IP,Orebrand M,Lima M,Pereira B,Volpert O,Quaggin SE,Jeansson M

    更新日期:2017-08-11 00:00:00

  • The mutation of BCOR is highly recurrent and oncogenic in mature T-cell lymphoma.

    abstract:BACKGROUND:BCOR acts as a corepressor of BCL6, a potent oncogenic protein in cancers of the lymphoid lineage. We have found the recurrent somatic mutation of BCOR occurred in mature T-cell lymphoma (TCL). The role of BCOR mutation in lymphoid malignancies is unknown. METHODS:Lymphoma patient samples were analyzed to i...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-021-07806-8

    authors: Kang JH,Lee SH,Lee J,Choi M,Cho J,Kim SJ,Kim WS,Ko YH,Yoo HY

    更新日期:2021-01-19 00:00:00

  • An immunochemistry-based screen for chemical inhibitors of DNA-protein interactions and its application to human CGGBP1.

    abstract:BACKGROUND:Inhibition of DNA-binding of proteins by small-molecule chemicals holds immense potential in manipulating the activities of DNA-binding proteins. Such a chemical inhibition of DNA-binding of proteins can be used to modulate processes such as replication, transcription, DNA repair and maintenance of epigeneti...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07526-5

    authors: Patel M,Patel D,Datta S,Singh U

    更新日期:2020-10-20 00:00:00

  • Exome profiling of primary, metastatic and recurrent ovarian carcinomas in a BRCA1-positive patient.

    abstract:BACKGROUND:Ovarian carcinoma is a common, and often deadly, gynecological cancer. Mutations in BRCA1 and BRCA2 genes are present in at least a fifth of patients. Uncovering other genes that become mutated subsequent to BRCA1/BRCA2 inactivation during cancer development will be helpful for more effective treatments. ME...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-146

    authors: Zhang J,Shi Y,Lalonde E,Li L,Cavallone L,Ferenczy A,Gotlieb WH,Foulkes WD,Majewski J

    更新日期:2013-03-22 00:00:00

  • Pharmacological modulation of autophagy enhances Newcastle disease virus-mediated oncolysis in drug-resistant lung cancer cells.

    abstract:BACKGROUND:Oncolytic viruses represent a promising therapy against cancers with acquired drug resistance. However, low efficacy limits its clinical application. The objective of this study is to investigate whether pharmacologically modulating autophagy could enhance oncolytic Newcastle disease virus (NDV) strain NDV/F...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-551

    authors: Jiang K,Li Y,Zhu Q,Xu J,Wang Y,Deng W,Liu Q,Zhang G,Meng S

    更新日期:2014-07-30 00:00:00

  • p300 promotes proliferation, migration, and invasion via inducing epithelial-mesenchymal transition in non-small cell lung cancer cells.

    abstract:BACKGROUND:Histone acetyltransferase p300 is a crucial transcriptional coactivator and has been implicated as a poor prognostic factor in human cancers. However, little is known about the substantial functions and mechanisms of p300 in NSCLC proliferation and distant metastasis. METHODS:We constructed p300 down-regula...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4559-3

    authors: Hou X,Gong R,Zhan J,Zhou T,Ma Y,Zhao Y,Zhang Y,Chen G,Zhang Z,Ma S,Chen X,Gao F,Hong S,Luo F,Fang W,Yang Y,Huang Y,Chen L,Yang H,Zhang L

    更新日期:2018-06-07 00:00:00

  • NR2F2 plays a major role in insulin-induced epithelial-mesenchymal transition in breast cancer cells.

    abstract:BACKGROUND:The failure of treatment for breast cancer usually results from distant metastasis in which the epithelial-mesenchymal transition (EMT) plays a critical role. Hyperinsulinemia, the hallmark of Type 2 diabetes mellitus (T2DM), has been regarded as a key risk factor for the progression of breast cancer. Nuclea...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07107-6

    authors: Xia B,Hou L,Kang H,Chang W,Liu Y,Zhang Y,Ding Y

    更新日期:2020-07-06 00:00:00

  • Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis.

    abstract:BACKGROUND:Treatment of locally advanced non-small-cell lung cancer is based on a combined approach. To study the impact of trimodal therapy for stage III-N2 NSCLC a single centre retrospective evaluation focusing on survival and therapy-related toxicity was performed. METHODS:71 patients diagnosed between March 2001 ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-572

    authors: Askoxylakis V,Tanner J,Kappes J,Hoffmann H,Nicolay NH,Rief H,Debus J,Thomas M,Bischof M

    更新日期:2014-08-07 00:00:00

  • Attention to the principles of exercise training in exercise studies on prostate cancer survivors: a systematic review.

    abstract:BACKGROUND:The purpose of this review is to update previously published reviews on exercise programming in exercise trials in prostate cancer survivors. We evaluated: 1) the application of the principles of exercise training in prescribed programs; 2) the reporting of the components of the exercise prescription; and 3)...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5520-9

    authors: Neil-Sztramko SE,Medysky ME,Campbell KL,Bland KA,Winters-Stone KM

    更新日期:2019-04-05 00:00:00

  • The effects of fluorouracil, epirubicin, and cyclophosphamide (FEC60) on the intestinal barrier function and gut peptides in breast cancer patients: an observational study.

    abstract:BACKGROUND:Several GI peptides linked to intestinal barrier function could be involved in the modification of intestinal permeability and the onset of diarrhea during adjuvant chemotherapy. The aim of the study was to evaluate the circulating levels of zonulin, glucagon-like peptide-2 (GLP-2), epidermal growth factor (...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/1471-2407-13-56

    authors: Russo F,Linsalata M,Clemente C,D'Attoma B,Orlando A,Campanella G,Giotta F,Riezzo G

    更新日期:2013-02-04 00:00:00

  • Predictors of persistent cytologic abnormalities after treatment of cervical intraepithelial neoplasia in Soweto, South Africa: a cohort study in a HIV high prevalence population.

    abstract:BACKGROUND:In the presence of both HIV infection and cervical intraepithelial neoplasia (CIN), the risk of cancer development despite treatment may be greater. We investigated clinical predictors of persistent cytological abnormalities in women who had had a large loop excision of the transformation zone (LLETZ). METH...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-211

    authors: Adam Y,van Gelderen CJ,de Bruyn G,McIntyre JA,Turton DA,Martinson NA

    更新日期:2008-07-25 00:00:00

  • Impact of diabetes type II and chronic inflammation on pancreatic cancer.

    abstract:BACKGROUND:We explored if known risk factors for pancreatic cancer such as type II diabetes and chronic inflammation, influence the pathophysiology of an established primary tumor in the pancreas and if administration of metformin has an impact on tumor growth. METHODS:Pancreatic carcinomas were assessed in a syngenei...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1047-x

    authors: Zechner D,Radecke T,Amme J,Bürtin F,Albert AC,Partecke LI,Vollmar B

    更新日期:2015-02-13 00:00:00

  • Mutation analysis by deep sequencing of pancreatic juice from patients with pancreatic ductal adenocarcinoma.

    abstract:BACKGROUND:Reliable methods are needed to identify patients with early-stage cancer or high-grade precancerous lesions in the pancreas. Analysis of pancreatic juice to detect somatic mutations could represent one such approach. Here we investigated the concordance between mutations found in the primary tumor and pancre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5195-7

    authors: Choi MH,Mejlænder-Andersen E,Manueldas S,El Jellas K,Steine SJ,Tjensvoll K,Sætran HA,Knappskog S,Hoem D,Nordgård O,Hovland R,Molven A

    更新日期:2019-01-05 00:00:00

  • Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).

    abstract:BACKGROUND:Triple-negative breast cancer (TNBC) comprises a heterogeneous group of diseases which are generally associated with poor prognosis. Up to now, no targeted treatment beyond anti-VEGF therapy has been approved for TNBC and cytotoxic agents remain the mainstay of treatment. Ixazomib is a selective and reversib...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4979-0

    authors: Rinnerthaler G,Gampenrieder SP,Petzer A,Burgstaller S,Fuchs D,Rossmann D,Balic M,Egle D,Rumpold H,Singer CF,Bartsch R,Petru E,Melchardt T,Ulmer H,Mlineritsch B,Greil R

    更新日期:2018-11-06 00:00:00

  • Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years.

    abstract:BACKGROUND:The aim of this population-based study was to assess independent prognostic factors in ovarian cancer using relative survival (RS) and to investigate changes in RS rates from 1982 to 2005. METHODS:Data on 748 patients with ovarian cancer were provided by the Côte d'Or gynaecologic cancer registry. The RS wa...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-622

    authors: Hamidou Z,Causeret S,Dabakuyo TS,Gentil J,Arnould L,Roignot P,Altwegg T,Poillot ML,Bonnetain F,Arveux P

    更新日期:2010-11-10 00:00:00

  • Myopericytoma occurrence in the liver and stomach space: imaging performance.

    abstract:BACKGROUND:Myopericytoma is a rare and usually benign tumor, which is even rarer if it occurs in the liver and stomach space. Previous reports of myopericytoma were mostly related to its pathological manifestations, while imaging reports were rare. Here, we report the computed tomography (CT), computed tomography angio...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3146-3

    authors: Chen Z,Liang W

    更新日期:2017-02-20 00:00:00

  • Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.

    abstract:BACKGROUND:To validate the robust predictive values of tumor vascularity and hand-foot-skin reaction (HFSR) in combination treatment of transarterial chemoembolization (TACE) and sorafenib for patients with intermediate hepatocellular carcinoma (HCC), and then select the potential candidates who would survive best from...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5570-z

    authors: Wang E,Xia D,Bai W,Yuan J,Li X,Niu J,Yin Z,Xia J,Cai H,Fan D,Han G,Liu L

    更新日期:2019-04-30 00:00:00